INC.;THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE
发明人:
PEOPLES, GEORGE,PONNIAH, SATHIBALAN
申请号：
EP09832462
公开号：
EP2355843A4
申请日:
2009.12.09
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
Provided are methods to induce and maintain a protective cytotoxic T-lymphocyte response to a peptide of the HER2/ neu oncogene, GP2, with the effect of inducing and maintaining protective or therapeutic immunity against breast cancer in a patient in clinical remission, including patients having low to intermediate levels of HER2/ neu expression. The methods comprise administering to the patient an effective amount of a vaccine composition comprising a pharmaceutically acceptable carrier, an adjuvant such as GM-CSF, and the GP2 peptide. The methods may further comprise administering a periodic booster vaccine dose as needed due to declining GP2-specific T cell immunity. Also provided are vaccine compositions for use in the methods.
